Roche Holding Ltd ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $35.47
- Today's High:
- $35.74
- Open Price:
- $35.72
- 52W Low:
- $33.7184
- 52W High:
- $41.7696
- Prev. Close:
- $35.84
- Volume:
- 1481407
Company Statistics
- Market Cap.:
- $230.26 billion
- Book Value:
- 4.15
- Revenue TTM:
- $63.14 billion
- Operating Margin TTM:
- 31.09%
- Gross Profit TTM:
- $47.83 billion
- Profit Margin:
- 17.47%
- Return on Assets TTM:
- 14.34%
- Return on Equity TTM:
- 40.25%
Company Profile
Roche Holding Ltd ADR had its IPO on under the ticker symbol RHHBY.
The company operates in the Healthcare sector and Drug Manufacturers-General industry. Roche Holding Ltd ADR has a staff strength of 103,613 employees.
Stock update
Shares of Roche Holding Ltd ADR opened at $35.72 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $35.47 - $35.74, and closed at $35.49.
This is a -0.98% slip from the previous day's closing price.
A total volume of 1,481,407 shares were traded at the close of the day’s session.
In the last one week, shares of Roche Holding Ltd ADR have slipped by -3.11%.
Roche Holding Ltd ADR's Key Ratios
Roche Holding Ltd ADR has a market cap of $230.26 billion, indicating a price to book ratio of 9.8089 and a price to sales ratio of 3.9935.
In the last 12-months Roche Holding Ltd ADR’s revenue was $63.14 billion with a gross profit of $47.83 billion and an EBITDA of $23.00 billion. The EBITDA ratio measures Roche Holding Ltd ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Roche Holding Ltd ADR’s operating margin was 31.09% while its return on assets stood at 14.34% with a return of equity of 40.25%.
In Q4, Roche Holding Ltd ADR’s quarterly earnings growth was a negative -15.8% while revenue growth was a negative 9.7%.
Roche Holding Ltd ADR’s PE and PEG Ratio
- Forward PE
- 14.4718
- Trailing PE
- 18.4844
- PEG
- 3.5274
Its diluted EPS in the last 12-months stands at $1.92 per share while it has a forward price to earnings multiple of 14.4718 and a PEG multiple of 3.5274. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Roche Holding Ltd ADR’s profitability.
Roche Holding Ltd ADR stock is trading at a EV to sales ratio of 4.5542 and a EV to EBITDA ratio of 12.7037. Its price to sales ratio in the trailing 12-months stood at 3.9935.
Roche Holding Ltd ADR stock pays annual dividends of $9.5 per share, indicating a yield of 3.61% and a payout ratio of 40.09%.
Balance sheet and cash flow metrics
- Total Assets
- $84.37 billion
- Total Liabilities
- $26.21 billion
- Operating Cash Flow
- $-3536000000.00
- Capital Expenditure
- $4.80 billion
- Dividend Payout Ratio
- 40.09%
Roche Holding Ltd ADR ended 2024 with $84.37 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $84.37 billion while shareholder equity stood at $26.52 billion.
Roche Holding Ltd ADR ended 2024 with $0 in deferred long-term liabilities, $26.21 billion in other current liabilities, in common stock, $38.33 billion in retained earnings and $10.56 billion in goodwill. Its cash balance stood at $3.72 billion and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $20.35 billion.
Roche Holding Ltd ADR’s total current assets stands at $30.98 billion while long-term investments were $0 and short-term investments were $3.79 billion. Its net receivables were $11.09 billion compared to accounts payable of $4.06 billion and inventory worth $8.50 billion.
In 2024, Roche Holding Ltd ADR's operating cash flow was $-3536000000.00 while its capital expenditure stood at $4.80 billion.
Comparatively, Roche Holding Ltd ADR paid $0.40 in dividends in 2024.
Other key metrics
- Current Trading Price
- $35.49
- 52-Week High
- $41.7696
- 52-Week Low
- $33.7184
- Analyst Target Price
- $
Roche Holding Ltd ADR stock is currently trading at $35.49 per share. It touched a 52-week high of $41.7696 and a 52-week low of $41.7696. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $37.66 and 200-day moving average was $37.87 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 156.3% are held by institutions.
Frequently Asked Questions About Roche Holding Ltd ADR
Similar Industry Stocks (Drug Manufacturers-General)
Most Active
Top Gainers
Top Losers
About
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.